Connection

Elizabeth Garrett-Mayer to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Elizabeth Garrett-Mayer
Connection Strength
0.080
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate. Clin Cancer Res. 2010 Jan 01; 16(1):338-47.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.